1 articles with this tag
SNIPR Biome, a Danish biotech, secured €35 million in Series B funding. New investors Cystic Fibrosis Foundation and SPRIN-D joined the round, alongside existing backers. This capital will advance its microbial CRISPR-medicine development, including therapies for cystic fibrosis and antimicrobial resistance.
